Literature DB >> 18085216

Biological scaffolds for heart valve tissue engineering.

Artur Lichtenberg1, Serghei Cebotari, Igor Tudorache, Andres Hilfiker, Axel Haverich.   

Abstract

Tissue engineering might bear promising solutions for overcoming the limitations of biological and mechanical heart valve substitutes. The concept of heart valve tissue engineering bases on decellularized biological matrices, as removal of cellular components might reduce immunological reactions, which are thought to be responsible for accelerated valvular graft deterioration and their subsequent repopulation with autologous cells, which leads to tissue integrity and continuous remodeling. Here, we report a method for efficient removal of cells from ovine heart valve tissue (including cusp, wall, and myocardial cuff) by detergents for the generation of biological valvular scaffolds.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18085216     DOI: 10.1007/978-1-59745-443-8_17

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  4 in total

1.  Fabrication of a novel hybrid scaffold for tissue engineered heart valve.

Authors:  Hao Hong; Nianguo Dong; Jiawei Shi; Si Chen; Chao Guo; Ping Hu; Hongxu Qi
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-10-11

Review 2.  Tissue engineering on matrix: future of autologous tissue replacement.

Authors:  Benedikt Weber; Maximilian Y Emmert; Roman Schoenauer; Chad Brokopp; Laura Baumgartner; Simon P Hoerstrup
Journal:  Semin Immunopathol       Date:  2011-01-29       Impact factor: 9.623

3.  Lectin and antibody-based histochemical techniques for cardiovascular tissue engineering.

Authors:  Agneta Simionescu; Mary E Tedder; Ting-Hsien Chuang; Dan T Simionescu
Journal:  J Histotechnol       Date:  2011-03       Impact factor: 0.714

4.  Creation of a Rodent Model of Abdominal Aortic Aneurysm by Blocking Adventitial Vasa Vasorum Perfusion.

Authors:  Hiroki Tanaka; Naoki Unno; Tatsuro Yata; Hirona Kugo; Nobuhiro Zaima; Takeshi Sasaki; Tetsumei Urano
Journal:  J Vis Exp       Date:  2017-11-08       Impact factor: 1.355

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.